The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up
Augusto Lombardi, Rachele Lazzeroni, Laura Bersigotti, Valeria Vitale, Claudio Amanti Department of Breast Surgery, Università di Roma La Sapienza – OspedaleSant’Andrea, Rome, ItalyCorrespondence: Laura BersigottiOspedaleSant’Andrea, via di Grottarossa 1035,...
Main Authors: | Lombardi A, Lazzeroni R, Bersigotti L, Vitale V, Amanti C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | Breast Cancer: Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-proper-ki-67-cut-off-in-hormone-responsive-breast-cancer-a-monoins-peer-reviewed-article-BCTT |
Similar Items
-
Clinicopathologic study and Ki-67 proliferative marker evaluation in human osteosarcomas Estudo clinicopatológico com avaliação do índice de proliferação celular avaliado pelo Ki-67 em osteossarcomas humanos
by: Larissa Cardoso Marinho, et al.
Published: (2005-12-01) -
Gene experison of cell proliferative marker Ki67 in breast cancer
by: Golmohammadi R (PhD), et al.
Published: (2011-09-01) -
Expression and Clinical Significance of Heparanase and Ki-67 in Non-small Cell Lung Cancer
by: Xiaoming QIU, et al.
Published: (2009-07-01) -
Ki-67 expression as an indicator of invasiveness in patients with breast cancer
by: Ahmed Salah Mahdi, et al.
Published: (2018-01-01) -
Accuracy of p53 and ki-67 in the graduation of phyllodes tumor, a model for practical application
by: L. F. Rivero, et al.
Published: (2020-02-01)